STAA
STAAR Surgical CompanyNASDAQHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$1.62B
P/E Ratio
—
EPS
$-0.42
Beta
1.20
52W High
$35.87
52W Low
$15.59
50-Day MA
$24.51
200-Day MA
$24.23
Dividend Yield
—
Profit Margin
-7.24%
Forward P/E
140.85
PEG Ratio
0.76
About STAAR Surgical Company
STAAR Surgical Company designs, develops, manufactures, markets and sells implantable eye lenses and supplemental delivery systems for placing the lenses in the eye. The company is headquartered in Lake Forest, California.
Fundamentals
| Revenue (TTM) | $290.38M |
| Gross Profit (TTM) | $223.27M |
| EBITDA | $14.51M |
| Operating Margin | 18.70% |
| Return on Equity | -5.99% |
| Return on Assets | 0.88% |
| Revenue/Share (TTM) | $5.84 |
| Book Value | $6.97 |
| Price-to-Book | 4.59 |
| Price-to-Sales (TTM) | 5.57 |
| EV/Revenue | 5.13 |
| EV/EBITDA | 101.07 |
| Quarterly Earnings Growth (YoY) | -10.50% |
| Quarterly Revenue Growth (YoY) | 119.60% |
| Shares Outstanding | $49.79M |
| Float | $24.60M |
| % Insiders | 0.72% |
| % Institutions | 113.83% |
Historical Volatility
HV 10-Day
46.07%
HV 20-Day
45.18%
HV 30-Day
49.62%
HV 60-Day
63.19%
HV Rank
31.3%
Volatility is currently contracting
Analyst Ratings
Consensus ($29.67 target)
2
Buy9
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026